EOCN — Galmed Pharmaceuticals Ltd.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1595353 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 — -2,775,000 -2,723,000 18,283,000 2,885,000 5,545,000
Mar 2026 0 — -2,044,000 -1,910,000 16,027,000 1,600,000 2,079,000
Dec 2025 0 — -3,042,000 -4,818,000 18,627,000 3,985,000 2,845,000
Sep 2025 0 — -2,095,000 -1,892,000 21,584,000 3,314,000 2,472,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-8,543,000
Investing CF
$3,820,000
Financing CF
$2,680,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-12.88
As of
2026-09-13

Balance + Analyst (yfinance extras)

Retained Earnings
$-215,411,000
Inventory
—
Receivables
$323,000
ST Investments
$8,346,000
EBIT TTM
$-9,956,000
Pretax Income TTM
$-11,343,000
Interest Exp TTM
—
Analysts
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -8,510,000 -10,309,000 18,627,000 2,845,000 15,782,000 -6,315,000
Dec 2024 0 -6,278,000 -7,517,000 18,500,000 2,173,000 16,327,000 -5,880,000
Dec 2023 0 -7,492,000 -6,912,000 16,629,000 2,750,000 13,879,000 -6,137,000
Dec 2022 0 -17,651,000 -17,866,000 16,561,000 3,138,000 13,423,000 -18,501,000
Dec 2021 — — — — — — —

Peers — same industry

TickerNameMarket CapLastDaily %
LLY ELI LILLY & Co $1.06T $1183.46 —
JNJ JOHNSON & JOHNSON $653.61B $271.22 —
ABBV AbbVie Inc. $467.12B $264.34 —
MRK Merck & Co., Inc. $367.07B $148.78 —
NVS NOVARTIS AG $276.48B $145.46 —

News headlines (Yahoo Finance, 1h cache)

Galmed Pharmaceuticals Becomes EoCene, Unveiling New Ticker Symbol "EOCN" to Reflect its New Dawn Platform for GI Innovation
2026-09-09 11:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.